| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.9 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sblendorio Glenn |
CEO |
• • – |
2022-03-30 |
4 |
OE |
$2.94 |
$3,566 |
D/D |
1,213 |
280,902 |
|
- |
|
| Carroll David Francis |
CFO |
• – – |
2022-03-25 |
4 |
AS |
$17.02 |
$285,387 |
D/D |
(16,772) |
62,935 |
|
-18% |
|
| Carroll David Francis |
CFO |
• – – |
2022-03-25 |
4 |
OE |
$1.45 |
$24,306 |
D/D |
16,763 |
79,707 |
|
- |
|
| Sblendorio Glenn |
CEO |
• • – |
2022-03-25 |
4 |
AS |
$17.06 |
$320,302 |
D/D |
(18,775) |
279,689 |
|
-18% |
|
| Sblendorio Glenn |
CEO |
• • – |
2022-03-25 |
4 |
OE |
$2.94 |
$55,199 |
D/D |
18,775 |
298,464 |
|
- |
|
| Sblendorio Glenn |
CEO |
• • – |
2022-03-18 |
4 |
AS |
$17.00 |
$59,145 |
D/D |
(3,479) |
279,689 |
|
-36% |
|
| Sblendorio Glenn |
CEO |
• • – |
2022-03-18 |
4 |
OE |
$2.94 |
$10,228 |
D/D |
3,479 |
283,168 |
|
- |
|
| Carroll David Francis |
CFO |
• – – |
2022-03-18 |
4 |
AS |
$17.00 |
$196,562 |
D/D |
(11,561) |
62,944 |
|
-36% |
|
| Carroll David Francis |
CFO |
• – – |
2022-03-18 |
4 |
OE |
$1.45 |
$11,944 |
D/D |
8,237 |
74,505 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2022-03-17 |
4 |
AS |
$15.06 |
$32,280 |
D/D |
(2,143) |
109,128 |
|
-33% |
|
| Westby Keith |
SVP & COO |
• – – |
2022-03-16 |
4 |
AS |
$15.01 |
$117,911 |
D/D |
(7,857) |
111,271 |
|
-27% |
|
| Westby Keith |
SVP & COO |
• – – |
2022-03-01 |
4 |
OE |
$1.65 |
$16,799 |
D/D |
10,169 |
118,449 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2022-02-15 |
4 |
AS |
$15.16 |
$151,634 |
D/D |
(10,000) |
108,280 |
|
-33% |
|
| Westby Keith |
SVP & COO |
• – – |
2022-02-07 |
4 |
AS |
$15.00 |
$150,033 |
D/D |
(10,000) |
118,280 |
|
-34% |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2022-01-03 |
4 |
S |
$16.39 |
$259,310 |
D/D |
(15,819) |
65,504 |
|
40% |
|
| Westby Keith |
SVP & COO |
• – – |
2022-01-03 |
4 |
S |
$16.39 |
$201,265 |
D/D |
(12,278) |
128,280 |
|
40% |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,500 |
81,323 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,500 |
140,558 |
|
- |
|
| Sblendorio Glenn |
CEO |
• • – |
2021-12-31 |
4 |
AS |
$17.01 |
$13,621 |
D/D |
(801) |
279,133 |
|
-39% |
|
| Sblendorio Glenn |
CEO |
• • – |
2021-12-31 |
4 |
OE |
$2.94 |
$2,355 |
D/D |
801 |
279,934 |
|
- |
|
| Sblendorio Glenn |
CEO |
• • – |
2021-12-30 |
4 |
AS |
$17.01 |
$1,701 |
D/D |
(100) |
279,133 |
|
-35% |
|
| Sblendorio Glenn |
CEO |
• • – |
2021-12-30 |
4 |
OE |
$2.94 |
$294 |
D/D |
100 |
279,233 |
|
- |
|
| Sblendorio Glenn |
CEO |
• • – |
2021-12-27 |
4 |
AS |
$16.64 |
$86,990 |
D/D |
(5,229) |
279,133 |
|
-20% |
|
| Sblendorio Glenn |
CEO |
• • – |
2021-12-27 |
4 |
OE |
$1.45 |
$7,582 |
D/D |
5,229 |
284,362 |
|
- |
|
| Sblendorio Glenn |
CEO |
• • – |
2021-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
279,133 |
|
- |
|
93 Records found
|
|
Page 2 of 4 |
|
|
